Final-Program-ATS-2023-AP.vp

312

WEDNESDAY • MAY 24

9:00 Secondary Pulmonary Hypertension Is Not a Useful Diagnostic Category in the Lung Allocation Score/ M. Sonnick, New York, NY 9:12 Coping Phenotypes Are Associated With Health-related Quality of Life in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR)/ K. Courtright, Philadelphia, PA 9:24 A 6-year Analysis of the Sustainability of an “Opt-out” EHR-triggered Tobacco Treatment Consult Service at a Large Safety-net Hospital/ A.L. Flores, Boston, MA 9:36 Fidelity and Impact of a Team Based Chronic Obstructive Pulmonary Disease Service Across Rural and Urban Veterans Affairs Medical Centers/ E. Portillo, Madison, WI 9:48 What Strategies Are Recommended for Potential Implementation of a National Lung Cancer Screening in Australia?/ N. Rankin, Carlton, Australia

9:00 Safety, Tolerability, and Efficacy of Axatilimab, a Colony-stimulating Factor 1 Receptor (CSF-1R) Humanized Antibody, in Advanced Chronic Graft-versus-host Disease-related Bronchiolitis Obliterans Syndrome/ V. Radojcic, Waltham, MA 9:12 Infants With Severe Viral Respiratory Illnesses and High Airway Epithelial Thymic Stromal Lymphopoietin (TSLP) Responses Have Enhanced Baseline Interferon (IFN) and Chemokine Signaling Activation/ A. Welham, Washington, DC 9:24 A Rhinovirus-A16 VP0 Vaccine Induces Homotypic Humoral and Cellular Immunity, and Following Heterotypic Rhinovirus-A01 Infection, Accelerates Virus Clearance and Induces Cross-strain IFN- g T Cell and Neutralising Antibody Responses/ C.J. Pyle, London, United Kingdom 9:36 Single Cell Analysis of Human Nasal Mucosal IgE Antibody Secreting Cells Reveals Newly Minted Phenotype/ R.P. Ramonell, Pittsburgh, PA

CLINICAL • TRANSLATIONAL MINI SYMPOSIUM

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

D15

OUTCOMES IN SARCOIDOSIS

D14

CUTTING EDGE CONCEPTS IN BEHAVIORAL SCIENCES AND HEALTH SERVICES RESEARCH

8:00 a.m. - 10:00 a.m.

Walter E. Washington Convention Center Room 202 B (Level 2)

Chairing: D.A. Culver, DO, Cleveland, OH W.P. Drake, MD, Nashville, TN

8:00 a.m. - 10:00 a.m.

Walter E. Washington Convention Center Room 102 A-B (Street Level)

K. Buschulte, MD, Heidelberg, Germany

Chairing: A.E. Turnbull, DVM, MPH, PhD, Baltimore, MD S.M. Nyenhuis, MD, Chicago, IL K.C. Vranas, MD, MSCR, Portland, OR Oral Presentations: 8:00 An EHR-based Artificial Intelligence Approach to Identifying Patient-level Interprofessional Clinician Teams in the ICU/ H. Ratliff, Ann Arbor, MI 8:12 Artificial Intelligence-assisted Versus Clinician Only Evaluation of Indeterminate Pulmonary Nodules: A Comparative Effectiveness Study/ C.M. Godfrey, Nashville, TN 8:24 Modeling Normal Pulmonary Function Using Latent Class Analysis/ A.T. Moffett, Philadelphia, PA 8:36 Use of Latent Class Analysis to Identify Distinct Phenotypes of Long COVID/ A.W. Wong, Vancouver, Canada 8:48 Crisis Standards of Care Exclusion and Triage Score Modifier Performance in Predicting Hospital Mortality/ B.C. Walsh, Los Angeles, CA

Featured Speaker: 8:00 Outcomes in Sarcoidosis/ L.A. Maier, Denver, CO Oral Presentations: 8:12 Assessing Missed Opportunities To Diagnose Sarcoidosis: A Population-based Cohort Study/ S. De La Serna, Iowa City, IA 8:24 Ocular Manifestations of Sarcoidosis in the United States: A Nationwide Registry Study/ M. Younis, Gainesville, FL 8:36 Organ Involvement Clusters in Black and White Sarcoidosis Patients/ A.M. Tauquir, Cleveland, OH 8:48 Impact of Insurance Type on Morbidity and Mortality in Patients With Sarcoidosis/ A. Randhawa, Newark, NJ 9:00 Sarcoidosis: Racial Differences in Pulmonary Function Over Time/ M. Sharp, Baltimore, MD 9:12 Longer Travel Distance to Subspecialty Clinic Associates With Lower Lung Function in Pulmonary Sarcoidosis/ N. Farah, Charlottesville, VA

ATS 2023 • Washington, DC